These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18855244)

  • 21. A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder.
    Schieber FC; Boulton DW; Balch AH; Croop R; Mallikaarjun S; Benson J; Carlson BX
    Hum Psychopharmacol; 2009 Mar; 24(2):145-52. PubMed ID: 19132712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.
    Zimbroff DL; Marcus RN; Manos G; Stock E; McQuade RD; Auby P; Oren DA
    J Clin Psychopharmacol; 2007 Apr; 27(2):171-6. PubMed ID: 17414241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease.
    Streim JE; Porsteinsson AP; Breder CD; Swanink R; Marcus R; McQuade R; Carson WH
    Am J Geriatr Psychiatry; 2008 Jul; 16(7):537-50. PubMed ID: 18591574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of the safety and tolerability of aripiprazole.
    Pae CU
    Expert Opin Drug Saf; 2009 May; 8(3):373-86. PubMed ID: 19505266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophrenia.
    Fleischhacker WW; Sanchez R; Johnson B; Jin N; Forbes RA; McQuade R; Baker RA; Carson W; Kane JM
    Int Clin Psychopharmacol; 2013 Jul; 28(4):171-6. PubMed ID: 23615694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of aripiprazole on the subscales of the Kellner Symptom Questionnaire in treatment resistant depression.
    Dording C; Cassiello C; King F; Pencina M; Fava M; Mischoulon D
    Int Clin Psychopharmacol; 2013 Sep; 28(5):238-44. PubMed ID: 23764521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of acute dystonia after single dose of aripiprazole in a man with cocaine dependence.
    Henderson JB; Labbate L; Worley M
    Am J Addict; 2007; 16(3):244. PubMed ID: 17612831
    [No Abstract]   [Full Text] [Related]  

  • 28. Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study.
    Andrezina R; Marcus RN; Oren DA; Manos G; Stock E; Carson WH; McQuade RD
    Curr Med Res Opin; 2006 Nov; 22(11):2209-19. PubMed ID: 17076982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers.
    Mallikaarjun S; Salazar DE; Bramer SL
    J Clin Pharmacol; 2004 Feb; 44(2):179-87. PubMed ID: 14747427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Torticollis after low-dose aripiprazole administration in a Thai schizophrenia patient.
    Ittasakul P; Srivastava S; Hiranyatheb T; Ketter TA
    Asian J Psychiatr; 2012 Dec; 5(4):365-6. PubMed ID: 23174451
    [No Abstract]   [Full Text] [Related]  

  • 31. A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia.
    Findling RL; Robb A; Nyilas M; Forbes RA; Jin N; Ivanova S; Marcus R; McQuade RD; Iwamoto T; Carson WH
    Am J Psychiatry; 2008 Nov; 165(11):1432-41. PubMed ID: 18765484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aripiprazole and the neuroleptic malignant syndrome.
    Strawn JR
    Schizophr Res; 2006 Jul; 85(1-3):298-9. PubMed ID: 16678389
    [No Abstract]   [Full Text] [Related]  

  • 33. Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse.
    Feltenstein MW; Altar CA; See RE
    Biol Psychiatry; 2007 Mar; 61(5):582-90. PubMed ID: 16806092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.
    Newton TF; Reid MS; De La Garza R; Mahoney JJ; Abad A; Condos R; Palamar J; Halkitis PN; Mojisak J; Anderson A; Li SH; Elkashef A
    Int J Neuropsychopharmacol; 2008 Dec; 11(8):1037-45. PubMed ID: 18664303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychosocial functioning in patients with schizophrenia treated with aripiprazole - an office-based real-world setting. Results from the German post-marketing surveillance study.
    Bergmann F; Zacher A; Nass A; Urban R; Werner C; Spevakné-Göröcs T; Kungel M; Ebrecht M; Modell S
    Pharmacopsychiatry; 2009 May; 42(3):101-8. PubMed ID: 19452378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperprolactinemia with aripiprazole: understanding the paradox.
    Saraf G; Behere RV; Venkatasubramanian G; Rao NP; Varambally S; Gangadhar BN
    Am J Ther; 2014; 21(3):e80-1. PubMed ID: 22357167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerability and pharmacokinetics of aripiprazole in children and adolescents with psychiatric disorders: an open-label, dose-escalation study.
    Findling RL; Kauffman RE; Sallee FR; Carson WH; Nyilas M; Mallikaarjun S; Shoaf SE; Forbes RA; Boulton DW; Pikalov A
    J Clin Psychopharmacol; 2008 Aug; 28(4):441-6. PubMed ID: 18626272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic malignant syndrome with the addition of aripiprazole to olanzapine.
    Marshall PB; Mellman TA; Nguyen SX
    Am J Psychiatry; 2008 Nov; 165(11):1488-9. PubMed ID: 18981078
    [No Abstract]   [Full Text] [Related]  

  • 39. Effectiveness and tolerability of switching to aripiprazole from risperidone in subjects with autism spectrum disorders: a prospective open-label study.
    Ishitobi M; Kosaka H; Takahashi T; Yatuga C; Asano M; Tanaka Y; Ueno K; Okazaki R; Omori M; Hiratani M; Tomoda A; Wada Y
    Clin Neuropharmacol; 2013; 36(5):151-6. PubMed ID: 24045605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intramuscular aripiprazole in the control of agitation.
    Currier GW; Citrome LL; Zimbroff DL; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
    J Psychiatr Pract; 2007 May; 13(3):159-69. PubMed ID: 17522559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.